Ngā hua rapu - Guryanova, Olga A
- E whakaatu ana i te 1 - 20 hua o te 23
- Haere ki te Whārangi Whai Ake
-
1
-
2
-
3
-
4
-
5
-
6
Combination strategies to promote sensitivity to cytarabine-induced replication stress in acute myeloid leukemia with and without DNMT3A mutations mā Shabashvili, Daniil E, Feng, Yang, Kaur, Prabhjot, Venugopal, Kartika, Guryanova, Olga A
I whakaputaina 2022Text -
7
-
8
-
9
-
10
DNMT3A alterations associated with myeloid malignancies dictate differential responses to hypomethylating agents mā Casellas Roman, Heidi L., Venugopal, Kartika, Feng, Yang, Shabashvili, Daniil E., Posada, Luisa M., Li, Jianping, Guryanova, Olga A.
I whakaputaina 2020Text -
11
Repurposing Tranexamic Acid as an Anticancer Agent mā Law, Mary E., Davis, Bradley J., Ghilardi, Amanda F., Yaaghubi, Elham, Dulloo, Zaafir M., Wang, Mengxiong, Guryanova, Olga A., Heldermon, Coy D., Jahn, Stephan C., Castellano, Ronald K., Law, Brian K.
I whakaputaina 2022Text -
12
Disulfide bond-disrupting agents activate the tumor necrosis family-related apoptosis-inducing ligand/death receptor 5 pathway mā Wang, Mengxiong, Law, Mary E., Davis, Bradley J., Yaaghubi, Elham, Ghilardi, Amanda F., Ferreira, Renan B., Chiang, Chi-Wu, Guryanova, Olga A., Kopinke, Daniel, Heldermon, Coy D., Castellano, Ronald K., Law, Brian K.
I whakaputaina 2019Text -
13
Loss of Dnmt3a Immortalizes Hematopoietic Stem Cells In Vivo mā Jeong, Mira, Park, Hyun Jung, Celik, Hamza, Ostrander, Elizabeth L., Reyes, Jaime M., Guzman, Anna, Rodriguez, Benjamin, Lei, Yong, Lee, Yeojin, Ding, Lei, Guryanova, Olga A., Li, Wei, Goodell, Margaret A., Challen, Grant A.
I whakaputaina 2018Text -
14
Curaxins: Anticancer Compounds that Simultaneously Suppress NF-κB and Activate p53 by Targeting FACT mā Gasparian, Alexander V., Burkhart, Catherine A., Purmal, Andrei A., Brodsky, Leonid, Pal, Mahadeb, Saranadasa, Madhi, Bosykh, Dmitry A., Commane, Mairead, Guryanova, Olga A., Pal, Srabani, Safina, Alfiya, Sviridov, Sergey, Koman, Igor E., Veith, Jean, Komar, Anton A., Gudkov, Andrei V., Gurova, Katerina V.
I whakaputaina 2011Text -
15
HOXBLINC long non-coding RNA activation promotes leukemogenesis in NPM1-mutant acute myeloid leukemia mā Zhu, Ganqian, Luo, Huacheng, Feng, Yang, Guryanova, Olga A., Xu, Jianfeng, Chen, Shi, Lai, Qian, Sharma, Arati, Xu, Bing, Zhao, Zhigang, Feng, Ru, Ni, Hongyu, Claxton, David, Guo, Ying, Mesa, Ruben A., Qiu, Yi, Yang, Feng-Chun, Li, Wei, Nimer, Stephen D., Huang, Suming, Xu, Mingjiang
I whakaputaina 2021Text -
16
Non-Receptor Tyrosine Kinase BMX Maintains Self-Renewal and Tumorigenic Potential of Glioblastoma Stem Cells by Activating STAT3 mā Guryanova, Olga A., Wu, Qiulian, Cheng, Lin, Lathia, Justin D., Huang, Zhi, Yang, Jinbo, MacSwords, Jennifer, Eyler, Christine E., McLendon, Roger E., Heddleston, John M., Shou, Weinian, Hambardzumyan, Dolores, Lee, Jeongwu, Hjelmeland, Anita B., Sloan, Andrew E., Bredel, Markus, Stark, George R., Rich, Jeremy N., Bao, Shideng
I whakaputaina 2011Text -
17
Epigenetic identity in AML depends on disruption of non-promoter regulatory elements and is affected by antagonistic effects of mutations in epigenetic modifiers mā Glass, Jacob L., Hassane, Duane, Wouters, Bas J., Kunimoto, Hiroyoshi, Avellino, Roberto, Garrett-Bakelman, Francine E., Guryanova, Olga A., Bowman, Robert, Redlich, Shira, Intlekofer, Andrew M., Meydan, Cem, Qin, Tingting, Fall, Mame, Alonso, Alicia, Guzman, Monica L., Valk, Peter J.M., Thompson, Craig B., Levine, Ross, Elemento, Olivier, Delwel, Ruud, Melnick, Ari, Figueroa, Maria E.
I whakaputaina 2017Text -
18
Ibrutinib inactivates BMX-STAT3 in glioma stem cells to impair malignant growth and radioresistance mā Shi, Yu, Guryanova, Olga A., Zhou, Wenchao, Liu, Chong, Huang, Zhi, Fang, Xiaoguang, Wang, Xiuxing, Chen, Cong, Wu, Qiulian, He, Zhicheng, Wang, Wei, Zhang, Wei, Jiang, Tao, Liu, Qing, Chen, Yaping, Wang, Wenying, Wu, Jingjing, Kim, Leo, Gimple, Ryan C., Feng, Hua, Kung, Hsiang-Fu, Yu, Jennifer S., Rich, Jeremy N., Ping, Yi-Fang, Bian, Xiu-Wu, Bao, Shideng
I whakaputaina 2018Text -
19
Dnmt3a Regulates Myeloproliferation and Liver-Specific Expansion of Hematopoietic Stem and Progenitor Cells mā Guryanova, Olga A., Lieu, Yen K., Garrett-Bakelman, Francine E., Spitzer, Barbara, Glass, Jacob L., Shank, Kaitlyn, Valencia Martinez, Ana Belen, Rivera, Sharon A., Durham, Benjamin H., Rapaport, Franck, Keller, Matthew D., Pandey, Suveg, Bastian, Lennart, Tovbin, Daniel, Weinstein, Abby R., Teruya-Feldstein, Julie, Abdel-Wahab, Omar, Santini, Valeria, Mason, Christopher E., Melnick, Ari M., Mukherjee, Siddhartha, Levine, Ross L.
I whakaputaina 2015Text -
20
Deletion of Asxl1 results in myelodysplasia and severe developmental defects in vivo mā Abdel-Wahab, Omar, Gao, Jie, Adli, Mazhar, Dey, Anwesha, Trimarchi, Thomas, Chung, Young Rock, Kuscu, Cem, Hricik, Todd, Ndiaye-Lobry, Delphine, LaFave, Lindsay M., Koche, Richard, Shih, Alan H., Guryanova, Olga A., Kim, Eunhee, Li, Sheng, Pandey, Suveg, Shin, Joseph Y., Telis, Leon, Liu, Jinfeng, Bhatt, Parva K., Monette, Sebastien, Zhao, Xinyang, Mason, Christopher E., Park, Christopher Y., Bernstein, Bradley E., Aifantis, Iannis, Levine, Ross L.
I whakaputaina 2013Text